View on Pubmed.gov 33897441 | View on doi.org 10.3389/fphar.2... | View the free full text Full text
Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis.
- Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
- West China School of Medicine, Sichuan University, Chengdu, China.
Abstract
Urinary tract infections (UTIs) are one of the most common bacterial infections acquired both in community and hospital. Fluoroquinolones, represented by levofloxacin and ciprofloxacin, are widely used for treatment of UTIs. However, it remains controversial for the comparison between the 2 drugs, which propelled us to conduct the first evidence-based research on this topic. To establish their relative efficacy and safety, we searched Pubmed, embase, and Web of Science for randomized controlled trials (RCTs) for UTIs. A total of 5 RCTs were finally included, involving 2,352 patients and a systematic review and meta-analysis were performed to compare the end-of-therapy and posttherapy clinical success rate, microbial eradication rate and adverse event rate. Jadad score and Review Manager 5.3.0 version were applied respectively to evaluate the study quality and heterogeneity. There was no significant difference between levofloxacin and ciprofloxacin group in end-of-therapy or posttherapy clinical success rate and microbial eradication rate ( > 0.05). As for adverse event rate, the 2 drugs were comparable and both safe for clinical use. Based on one included trial and pharmacological research, we raised hypothesis that levofloxacin was superior to ciprofloxacin for treatment of E. coli-induced chronic bacterial prostatitis (CBP) and it required a further study to prove it.
References
Int J Antimicrob Agents. 2012 Jun;40 Suppl:S37-43
J Med Microbiol. 2014 Jan;63(Pt 1):1-14
Curr Med Res Opin. 2007 Nov;23(11):2637-45
Andrology. 2016 Sep;4(5):800-7
Cited by 37 citations (total)
Journal Article
Genetic Determinants of Carbapenem and Fluoroquinolone Resistance in Isolates of Clinical Origin.
Electronic publication date April 4, 2025
Simbiat Tolani Lawal [...] Stella Smith et al.
BACKGROUND
Antimicrobial resistance has emerged as a global public health challenge, leading to higher mortality rates from infections that were once...
Journal Article Review
Research progress of extracellular vesicles in the pathogenesis of type IIIA chronic prostatitis.
Electronic publication date March 4, 2025
Le Cheng [...] Biao Qian et al.
Chronic prostatitis is a prevalent urological condition that significantly impacts patients' quality of life. Advances in the study of Extracellular...
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
Copyright
Copyright © 2021 Cao, Shen, Huang, Chen, Chen, Ai, Liu, Yang and Wei.